Suppr超能文献

相似文献

1
Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue.
Ann Neurol. 2015 Nov;78(5):787-800. doi: 10.1002/ana.24517. Epub 2015 Sep 25.
2
Autoradiography validation of novel tau PET tracer [F-18]-MK-6240 on human postmortem brain tissue.
Acta Neuropathol Commun. 2019 Mar 11;7(1):37. doi: 10.1186/s40478-019-0686-6.
3
Pathological correlations of [F-18]-AV-1451 imaging in non-alzheimer tauopathies.
Ann Neurol. 2017 Jan;81(1):117-128. doi: 10.1002/ana.24844.
4
An autoradiographic evaluation of AV-1451 Tau PET in dementia.
Acta Neuropathol Commun. 2016 Jun 13;4(1):58. doi: 10.1186/s40478-016-0315-6.
5
[F]-AV-1451 binding profile in chronic traumatic encephalopathy: a postmortem case series.
Acta Neuropathol Commun. 2019 Oct 28;7(1):164. doi: 10.1186/s40478-019-0808-1.
6
Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson's case.
Acta Neuropathol Commun. 2017 Oct 19;5(1):75. doi: 10.1186/s40478-017-0482-0.
10
Sensitivity-Specificity of Tau and Amyloid β Positron Emission Tomography in Frontotemporal Lobar Degeneration.
Ann Neurol. 2020 Nov;88(5):1009-1022. doi: 10.1002/ana.25893. Epub 2020 Sep 12.

引用本文的文献

2
Advances in PET imaging of protein aggregates associated with neurodegenerative disease.
Nat Rev Neurol. 2025 Aug 11. doi: 10.1038/s41582-025-01126-2.
3
Relationship between tau-PET and quantitative susceptibility mapping in atypical Alzheimer's disease.
Front Aging Neurosci. 2025 Jul 3;17:1615718. doi: 10.3389/fnagi.2025.1615718. eCollection 2025.
5
Cerebral blood flow is associated with plasma and PET biomarkers of tau pathology in middle age.
Brain Commun. 2025 Jun 19;7(4):fcaf249. doi: 10.1093/braincomms/fcaf249. eCollection 2025.
10
Relationships between hypometabolism and both β-amyloid and tau PET in corticobasal syndrome.
Alzheimers Dement. 2025 Mar;21(3):e70018. doi: 10.1002/alz.70018.

本文引用的文献

1
The A4 study: stopping AD before symptoms begin?
Sci Transl Med. 2014 Mar 19;6(228):228fs13. doi: 10.1126/scitranslmed.3007941.
2
Clinicopathologic assessment and imaging of tauopathies in neurodegenerative dementias.
Alzheimers Res Ther. 2014 Jan 2;6(1):1. doi: 10.1186/alzrt231. eCollection 2014.
3
A concise radiosynthesis of the tau radiopharmaceutical, [(18) F]T807.
J Labelled Comp Radiopharm. 2013 Dec;56(14):736-40. doi: 10.1002/jlcr.3098. Epub 2013 Jul 24.
5
Pathologic and gene expression features of metastatic melanomas to the brain.
Cancer. 2013 Aug 1;119(15):2737-46. doi: 10.1002/cncr.28029. Epub 2013 May 21.
6
[(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease.
Alzheimers Dement. 2013 Nov;9(6):666-76. doi: 10.1016/j.jalz.2012.11.008. Epub 2013 Feb 12.
7
Criteria for the diagnosis of corticobasal degeneration.
Neurology. 2013 Jan 29;80(5):496-503. doi: 10.1212/WNL.0b013e31827f0fd1.
8
Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807.
J Alzheimers Dis. 2013;34(2):457-68. doi: 10.3233/JAD-122059.
9
A highly selective and specific PET tracer for imaging of tau pathologies.
J Alzheimers Dis. 2012;31(3):601-12. doi: 10.3233/JAD-2012-120712.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验